Patient no.
|
Age
|
Contents (p.f.u) X Time
|
Injection site
|
Staginga (radiological)
|
Staginga (postoperative)
|
---|
Cohort 1
|
HF-1-02
|
60s
|
1X106X4
|
Pancreas head
|
III (T4N0M0)
|
NA
|
HF-1-04
|
60s
|
1X106X4
|
Pancreas head (uncinate process)
|
III (T4N0M0)
|
NA
|
HF-1-05
|
60s
|
1X106X4
|
Pancreas body
|
III (T4N0M0)
|
IIA (T3N0M0)
|
Cohort 2
|
HF-2-01
|
60s
|
3X106X4
|
Pancreas body
|
III (T4N0M0)
|
NA
|
HF-2-02
|
60s
|
3X106X4
|
Pancreas head (uncinate process)
|
III (T4N0M0)
|
IIA (T3N0M0)
|
HF-2-03
|
60s
|
3X106X4
|
Pancreas body
|
III (T4N0M0)
|
NA
|
Cohort 3
|
HF-3-01
|
60s
|
1X107X3
|
Pancreas body
|
III (T4N0M0)
|
NA
|
HF-3-02
|
50s
|
1X107X4
|
Pancreas head (uncinate process)
|
III (T4N0M0)
|
NA
|
HF-3-03
|
60s
|
1X107X4
|
Pancreas body
|
III (T4N0M0)
|
NA
|
HF-3-04
|
60s
|
1X107X4
|
Pancreas head
|
III (T4N0M0)
|
NA
|
- aBased on NCCN Clinical Practice Guidelines in Oncology [13]